510 Thread Cartridges |
| |||
16 of 283 products in 510 Thread Cartridges |
THC | 450 - 510mg/g (~48%) | VERY STRONG (P40) | 0 - 20mg/g (~1%) | CBD |
eweed.pro | INDICA | csmeter © |
2.6 ★★ (8)★ ☆ ☆☆ |
~$39.78 /g * |
ADD
$39.78 1g $39.78/g |
Citrus |
AROMA / FLVR |
||
+Floral | +Lemon |
Sleep |
AID** WITH |
||
+Inflammation | +Mood |
Potency | Very Strong (P40) | |
THC | 450 - 510mg/g | (45% - 51%) |
CBD | 0 - 20mg/g | (0% - 2%) |
Plant Type | Indica Dominant | |
Strain(s) | Dosidos, Purple Punch | |
Method | INDOOR | |
Extraction | CO2 | |
Producer | Northbound Cannabis by MediPharm Labs Inc. | |
GTIN# | 00628639000828 (1g) | |
Terpenes | Nerolidol, Limonene, Caryophyllene, Linalool |
Our Northbound Cannabis CBN Vape is a high-CBN (20-28%) formulation and indica-dominant hybrid inspired by Slurricane (a crossover between cultivars Do-Si-Dos and Purple Punch), with a sweet citrus-berry and creamy aroma that focuses on terpenes. It’s formulated at MediPharm Labs GMP facility using refined CBN material and individually sourced terpenes to create a high-quality, unique product.
UNIQUE CULTIVAR CROSSOVERS WITH MORE THAN 8% TERPS IN EVERY CARTRIDGE
We’ve created unique cultivar crossovers by taking some of your favourite strains and combining their terpene profiles to create flavourful hybrid formulations in each cartridge — all to provide a high-quality, high-value experience for you.
About MediPharm Labs Corp.
A leader in cannabis extraction and purification, MediPharm Labs has invested in an expert team, state-of-the-art technology, advanced methodologies and a purpose-built facility to deliver pure, safe and precisely-dosed cannabis concentrates and advanced derivative products.
Founded in 2015, MediPharm Labs Corp. is a pioneer in the cannabis industry and has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulations (ACMPR) without first receiving a cannabis cultivation license. This expert focus on cannabis concentrates from our cGMP (current Good Manufacturing Practices) and ISO standard clean rooms and critical environments laboratory, allows MediPharm to work with its established, Health Canada-approved cultivation partners to produce pharmaceutical-grade cannabis oil with a competitive advantage. MediPharm is research-driven and focused on downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification.